1 May 2020 - There is new hope for thousands of Australians with cardiovascular disease, rheumatoid arthritis and asthma with new and amended medicines listings on the Pharmaceutical Benefits Scheme from today.

To help reduce the risk of heart attack and stroke, the Australian Government is expanding subsidised access to a breakthrough medicine that combats high cholesterol, with up to 30,000 Australians per year expected to benefit.

Also from today, Australians with rheumatoid arthritis will benefit from the listing of Rinvoq (upadacitinib) on the PBS.

Read Minister of Health press release